marketcap
Facebook
Twitter
Telegram
Report an ErrorCatabasis Pharmaceuticals, Inc. Financial Statements 2011-2024 | CATB
Annual Financial Statements Catabasis Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
80.6 M | 61.9 M | 31.1 M | 32.1 M | 63.8 M | 53.2 M | - | - | - | - |
Shares |
19.4 M | 11.2 M | 5.05 M | 2.17 M | 1.62 M | 804 K | - | - | - | - |
Net Income |
-37.3 M | -26.3 M | -25.9 M | -27.4 M | -36.1 M | -32.6 M | -21.9 M | -18.1 M | - | - |
Revenue |
- | - | - | 500 K | - | - | - | - | - | - |
EBITDA |
-37.4 M | -27.1 M | -26.3 M | -26.8 M | -35.2 M | -31.5 M | -21.4 M | -17.8 M | - | - |
Operating Expenses |
37.4 M | 27.1 M | 26.4 M | 27.6 M | 35.6 M | 31.7 M | - | - | - | - |
General and Administrative Expenses |
11.8 M | 8.77 M | 9.33 M | 8.91 M | 10.1 M | 8.63 M | 6 M | 4.12 M | - | - |
All numbers in USD currency